designer drugs tirzepatide reddit Longevity Seekers Rethink Their Use of Metformin to Fight Aging Emerge moved me to designer

1B) indicated that in the NCD group, the kidneys were more echogenic than the liver, whereas in the HFD group, the liver echogenicity was notably higher than that in the kidneys

The recommendations are nonbinding, and final FDA action is still pending as of July 25, 2026

pTM (predicted template modeling score): A score above 0.5 suggests that the predicted overall complex fold is likely similar to the true structure

Safety and tolerability of the 7.2 mg weekly dose were consistent with the known profile of semaglutide, with gastrointestinal side effects remaining most common, except for a low discontinuation rate for adverse effects (about 3%)